Skip to content
Clinical Trials – home

Spitalul Clinic De Boli Infectioase Si Pneumoftiziologie Dr. Victor Babes Craiova

Research site

Romania Strada Calea Bucuresti, nr. 126, 200515 Craiova, Romania

  • Chronic obstructive pulmonary disease
  • Adult patients

About Specializations

Spitalul Clinic De Boli Infectioase Si Pneumoftiziologie Dr. Victor Babes Craiova in Craiova, Romania specialises in clinical trials of conditions such as Chronic obstructive pulmonary disease, and other specialisations. This site conducts important research.

Main research areas of the site

Respiratory Tract Diseases

The Pulmonology department at Spitalul Clinic De Boli Infectioase Si Pneumoftiziologie Dr. Victor Babes Craiova focuses on advancing care for patients with Respiratory Tract Diseases. Current trials are assessing a novel inhaled agent, CHF6001, added to standard triple therapy, with the goal of lowering the frequency of moderate and severe exacerbations in chronic lung conditions.

  • Chronic Obstructive Pulmonary Disease (COPD)
  • Chronic Bronchitis

By evaluating the added benefit of this therapy, researchers aim to improve long‑term outcomes and quality of life for individuals living with chronic respiratory illnesses.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Strada Calea Bucuresti, nr. 126200515 CraiovaRomania
Recruiting now
no trials
Conditions studied
1

More sites in CraiovaRomania

All trials

Ongoing trials

Clinical trials registered at this site – none is enrolling right now.

Condition
Type of trial
Recruitment status
Quick filters

2 clinical trials

Study on the Effectiveness and Safety of Tanimilast for Patients with Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Tanimilast
  • Sponsor:Chiesi Farmaceutici S.p.A.

Study on the Effectiveness and Safety of CHF6001 DPI with Roflumilast for Patients with Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Roflumilast
  • Sponsor:Chiesi Farmaceutici S.p.A.
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.